Literature DB >> 8695224

Cathepsin D and breast cancer.

B R Westley1, F E May.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695224     DOI: 10.1016/0959-8049(95)00530-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  12 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

2.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.

Authors:  M Beaujouin; S Baghdiguian; M Glondu-Lassis; G Berchem; E Liaudet-Coopman
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

4.  Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.

Authors:  D Nikolić-Vukosavljević; M Markićević; G Grujić-Adanja; A Petrović; K Kanjer; Z Nesković-Konstantinović
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors.

Authors:  P Majer; J R Collins; S V Gulnik; J W Erickson
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

6.  The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease.

Authors:  Tamara T Lah; Janko Kos; Andrej Blejec; Snezana Frkovic-Georgio; Rastko Golouh
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

7.  Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer.

Authors:  Marlene Wolf; Ian Clark-Lewis; Caroline Buri; Hanno Langen; Maddalena Lis; Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.

Authors:  T Jahkola; T Toivonen; K von Smitten; I Virtanen; V M Wasenius; C Blomqvist
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer.

Authors:  A Lösch; C Tempfer; P Kohlberger; E A Joura; M Denk; B Zajic; G Breitenecker; C Kainz
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

10.  Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.

Authors:  J A Foekens; M P Look; J Bolt-de Vries; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.